367 related articles for article (PubMed ID: 35719709)
1. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy.
Zhao W; Zhou L; Novák P; Shi X; Lin CB; Zhu X; Yin K
J Diabetes Res; 2022; 2022():2193768. PubMed ID: 35719709
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of traditional Chinese medicine in regulating NLRP3 inflammasomes to alleviate renal interstitial fibrosis in diabetic nephropathy: a review].
Qiao L; Jin Y; Guo ZA
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1164-1171. PubMed ID: 38621963
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
[TBL] [Abstract][Full Text] [Related]
5. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
[TBL] [Abstract][Full Text] [Related]
7. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
8. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
9. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
Qiu YY; Tang LQ
Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
[TBL] [Abstract][Full Text] [Related]
10. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
[TBL] [Abstract][Full Text] [Related]
11. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
12. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
[TBL] [Abstract][Full Text] [Related]
13. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
14. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
Wen L; Yang H; Ma L; Fu P
Mol Cell Biochem; 2021 Mar; 476(3):1377-1386. PubMed ID: 33389490
[TBL] [Abstract][Full Text] [Related]
15. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
Yang M; Zhao L
Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
17. ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy.
Chen K; Zhang J; Zhang W; Zhang J; Yang J; Li K; He Y
Int J Biochem Cell Biol; 2013 May; 45(5):932-43. PubMed ID: 23434541
[TBL] [Abstract][Full Text] [Related]
18. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
[TBL] [Abstract][Full Text] [Related]
19. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice.
Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B
J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184
[TBL] [Abstract][Full Text] [Related]
20. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
Li L; Qian K; Sun Y; Zhao Y; Zhou Y; Xue Y; Hong X
Bioengineered; 2021 Dec; 12(1):4805-4815. PubMed ID: 34338149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
